xamoterol has been researched along with ajmaline in 1 studies
| Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (ajmaline) | Trials (ajmaline) | Recent Studies (post-2010) (ajmaline) |
|---|---|---|---|---|---|
| 269 | 80 | 17 | 9 | 0 | 4 |
| Protein | Taxonomy | xamoterol (IC50) | ajmaline (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 1 | |
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 7 subunit alpha | Homo sapiens (human) | 8.2 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.04 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 11 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 8 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 10 subunit alpha | Homo sapiens (human) | 8.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
1 other study(ies) available for xamoterol and ajmaline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |